Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses in Healthy

Completed · Phase 1

Conditions studied: Healthy Subjects, Osteoarthritis

In brief

The purpose of this study is to evaluate the safety and tolerbility of ascending multiple oral doses of AGG-523 in healthy subjects and in subjects with osteoarthritis.

Key facts

Study ID

NCT00380900

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

Starts

2006-07-01

Expected to finish

2007-02-01

Last updated by the study team

2007-12-05

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy men or women, aged 18 to 40 years and subjects with osteoarthritis of the knee, aged 40 to 75 years.
• Women must be of non-childbearing potential, defined as surgically sterile with documentation of ultrasound.
• Must be nonsmoker or smoke less than 10 cigarettes per day.

Where it is running

• Study site — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.